Role of Crizotinib in previously treated non-small-cell lung cancer

被引:3
|
作者
Gupta, Sunil Kumar [1 ]
机构
[1] Rajiv Gandhi Canc Inst & Res Ctr, Dept Med Oncol, Head & Neck Med Serv, Sect 5, New Delhi, India
关键词
D O I
10.4103/2278-330X.130468
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:138 / 140
页数:3
相关论文
共 50 条
  • [1] PEMETREXED IN PREVIOUSLY TREATED NON-SMALL-CELL LUNG CANCER
    Cho, E.
    Hong, J.
    Kim, Y. S.
    Sim, S. J.
    Park, S. H.
    Park, J.
    Lee, J. H.
    Shin, D. B.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 120 - 120
  • [2] Docetaxel for previously treated non-small-cell lung cancer
    Fossella, FV
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (06): : 45 - 51
  • [3] Erlotinib in previously treated non-small-cell lung cancer
    Shepherd, FA
    Pereira, JR
    Ciuleanu, T
    Tan, EH
    Hirsh, V
    Thongprasert, S
    Campos, D
    Maoleekoonpiroj, S
    Smylie, M
    Martins, R
    van Kooten, M
    Dediu, M
    Findlay, B
    Tu, DS
    Johnston, D
    Bezjak, A
    Clark, G
    Santabárbara, P
    Seymour, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 123 - 132
  • [4] Crizotinib in the Treatment of Non-Small-Cell Lung Cancer
    Rothschild, Sacha I.
    Gautschi, Oliver
    [J]. CLINICAL LUNG CANCER, 2013, 14 (05) : 473 - 480
  • [5] Crizotinib in the treatment of non-small-cell lung cancer
    Forde, Patrick M.
    Rudin, Charles M.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (08) : 1195 - 1201
  • [6] Crizotinib for the treatment of non-small-cell lung cancer
    Timm, Andrew
    Kolesar, Jill M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (11) : 943 - 947
  • [7] Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Rogado, J.
    Pacheco-Barcia, V.
    Fenor De la Maza, M. D.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Obispo, B.
    Mondejar, R.
    Ballesteros, A.
    Donnay, O.
    Colomer, R.
    Sanchez-Torres, J. M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1915 - S1916
  • [8] Effect of Amrubicin in Patients with Previously Treated Non-Small-Cell Lung Cancer
    Takayama, S.
    Tamura, T.
    Kawajiri, T.
    Nishi, T.
    Kudo, K.
    Kuyama, S.
    Kawakado, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S937 - S937
  • [9] Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer
    Guo, Liting
    Zhang, Haijun
    Shao, Weiwei
    Chen, Baoan
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 5491 - 5497
  • [10] Carboplatin and paclitaxel for previously treated patients with non-small-cell lung cancer
    Roa, V
    Conner, A
    Mitchell, RB
    [J]. CANCER INVESTIGATION, 1998, 16 (06) : 381 - 384